Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

Eric J. Topol, David J. Moliterno, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, David J. Cohen, Eric A. Cohen, Michel Bertrand, Franz Josef Neumann, Gregg W. Stone, Peter M. Dibattiste, Laura Demopoulos, Steven J. Yakubov, Paul T. Delucca

Research output: Contribution to journal › Article › peer-review

713 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization'. Together they form a unique fingerprint.

Medicine and Dentistry